| Line Item | 2024-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.0M | -42.4% | — |
| R&D Expense | $7K | +0.0% | — |
| SG&A Expense | $2.1M | -26.5% | — |
| Operating Income | -$2.8M | +9.4% | — |
| Pre-tax Income | -$3.5M | +1.9% | — |
| Net Income | -$3.5M | +1.9% | — |
| EPS (Basic) | -$0.20 | +33.3% |
| Line Item | 2024-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $764K | -8.0% | -33.4% |
| Accounts Receivable | $837K | -31.8% | -25.6% |
| Current Assets | $11.9M | -20.1% | -30.4% |
| Total Assets | $12.9M | -34.3% | -59.3% |
| Current Liabilities | $19.0M | +4.4% | -8.9% |
| Long-term Debt |
| Line Item | 2024-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.7M | — | — |
| Investing Cash Flow | $500K | — | — |
| Financing Cash Flow | $3.5M | — | — |
| — |
| EPS (Diluted) | -$0.20 | +33.3% | — |
| $17.8M |
| -27.4% |
| -8.3% |
| Total Liabilities | $40.6M | -13.9% | -10.0% |
| Stockholders' Equity | -$27.7M | -0.5% | -106.2% |